R-Pharm suspends production of AstraZeneca vaccine for export
[ad_1]
The Russian pharmaceutical company R-Pharm has suspended production of AstraZeneca’s coronavirus vaccine for export due to lack of demand. This was announced by the CEO of the company Vasily Ignatiev.
“Now there is no demand (in the world.— “b”) for covid vaccines. It was produced when there was demand,” he said. TACC on the sidelines of the Biotechmed forum.
“R-Pharm” start vaccine production under license from Oxford University and AstraZeneca in September 2021. The Ministry of Industry and Trade said that the drug would be produced for export purposes. Vasily Ignatiev toldthat monthly planned to produce several hundred thousand doses. In March 2022, the Ministry of Health filed AstraZeneca vaccine application.
About the release of vaccines for export – in the material “Kommersant FM” “Sputnik V is aimed at Europe”.
[ad_2]
Source link
